Sunshine Biopharma Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Sunshine Biopharma Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Sunshine Biopharma Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $215K, a 426% increase year-over-year.
  • Sunshine Biopharma Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $114K, a 72% decline year-over-year.
  • Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2023 was $395K, a 69.4% increase from 2022.
  • Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2022 was $233K.
  • Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $395K +$162K +69.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $233K +$233K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-04-04
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.